These results verify that SphK1-mediated S1P production is increased in the injured brain after cerebral ischemia, and DSCXQ reduces the SphK1-induced S1P levels by suppressing S1PR1 receptors, which plays a crucial role in endothelial functions and vascular development. Here, SPHK1 is linked to brain ischemia.